← Open Payments lookup

KATIE HARP: Open Payments

NPI 1316612062 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,820 in 97 payments from 15 companies in 2025. Trend: 2023 $1,705 · 2024 $1,593 · 2025 $1,820

Food & beverage: $1,820
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.11$366
ABBVIE INC.29$349
Otsuka America Pharmaceutical, Inc.11$290
Vanda Pharmaceuticals Inc.10$209
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$101
Axsome Therapeutics, Inc.4$79
Corium, LLC7$76
Alkermes, Inc.6$74
Neurocrine BioSciences, Inc.3$58
Teva Pharmaceuticals USA, Inc.3$56

Products named: COBENFY, VRAYLAR, REXULTI, FANAPT, CAPLYTA, Auvelity, Azstarys, ABILIFY ASIMTUFII.

Industry payments across ID — which companies pay providers there.